Eric Bernhardt
Eric Bernhardt
bid company dollars fantastic offer price product reflect
There may be one or two dollars more in the bid but I think the price does reflect the business. If they had a fantastic product in late-stage testing, you'd offer more but you don't make a spectacular bid for a company that's not spectacular.
beginning
It's still the beginning, and the beginning is when you have to be tough.
blood business buy compared jewels portfolio rather vaccines
The jewels are the vaccines business and blood testing. There's nothing about Chiron that makes you say 'wow, we need to buy this for the pipeline.' The portfolio is rather lackluster compared to other biotechnology companies.